So-Young International Inc.
So-Young International Inc. (SY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
sy · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for So-Young International Inc. (SY) measures how much investors pay for each dollar of the company's trailing earnings. SY's current PE ratio of N/A is calculated by dividing its stock price of $1.83 by its TTM earnings per share of -$1.95.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%94.3x
MedianQ3 · 75%1720.2x
Max
At N/A, SY's current P/E is lower than in 0% of its annual fiscal year readings over the past 5 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
So-Young International Inc.You SY | $240M | N/A | — | -$1.95 |
 ADC Therapeutics S.A. ADCT | $124M | N/A | — | -$1.12 |
 Cullinan Therapeutics, Inc. CGEM | $816M | N/A | — | -$3.72 |
 Standard BioTools Inc. LAB | $314M | N/A | — | -$0.20 |
 Lexicon Pharmaceuticals, Inc. LXRX | $835M | N/A | — | -$0.14 |
 Neumora Therapeutics, Inc. Common Stock NMRA | $300M | N/A | — | -$1.45 |
 Omeros Corporation OMER | $713M | N/A | — | -$0.05 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.79 | — | |
2024-12-31 FY2024 | — | $-4.40 | — | |
2023-12-31 FY2023 | 57.30x | $0.16 | — | |
2022-12-31 FY2022 | — | $-0.47 | — | |
2021-12-31 FY2021 | — | $-0.06 | — | |
2020-12-31 FY2020 | 1720.18x | $0.04 | +3242.9% | |
2019-12-31 FY2019 | 51.46x | $1.65 | -45.4% | |
2018-12-31 FY2018 | 94.27x | $1.33 | -69.9% | |
2017-12-31 FY2017 | 312.73x | $0.38 | — | |
2016-12-31 FY2016 | — | $-1.78 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for So-Young International Inc. (SY) measures how much investors pay for each dollar of the company's trailing earnings. SY's current PE ratio of N/A is calculated by dividing its stock price of $1.83 by its TTM earnings per share of -$1.95.
Frequently asked questions
SY pe ratio · 6 questionsSY's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.83 and TTM EPS of -$1.95. Data sourced from Financial Modeling Prep via SY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · So-Young International Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08